Polpharma's ethical pursuit of its business objectives hinges upon the reliable fulfillment of such obligations as compliance with the law, payment of taxes and timely settlement of payments; Polpharma pays attention to all of these issues.

The company also contributes to the development of the Polish economy by undertaking new investments. With respect to marketing and sales, Polpharma observes the highest standards of fairness, by acting with an appropriate degree of professionalism, attention and due diligence in accordance with the provisions of the Pharmaceutical Law. Acting also outside of Poland, Polpharma conforms to the Principles of Performance in Pharmaceuticals Marketing as published by IFPMA (International Federation of Pharmaceutical Manufacturers’ Associations) and other regulations on marketing practices in force in various countries.

Polpharma continuously raises the quality of customer service. As the first Polish drug manufacturer, Polpharma has implemented an Electronic Data Interchange system (EDI), which allows for the replacement of such paper documents as offers, orders, order confirmations, and invoices with electronic files.

Polpharma keeps purchasing processes, and payments for them transparent. The company strictly observes negotiated terms of payment and duly settles all accounts. As proof of its timely payment of budget obligations, every month Polpharma receives statements from the Tax Office and the State Insurance Agency attesting that no delays in payments have occurred. It is a clear confirmation of the company’s financial reliability.